{"bill":{"bill_id":1196509,"change_hash":"361c6b37d0abff2534532a46eee21ad0","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB419\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/419\/all-info","completed":0,"status":1,"status_date":"2019-02-07","progress":[{"date":"2019-02-07","event":1},{"date":"2019-02-07","event":9}],"state":"US","state_id":52,"bill_number":"SB419","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"Protecting Americans from Dangerous Opioids Act","description":"Requires the Food and Drug Administration (FDA) to revoke approval for an opioid drug for every new opioid drug approved. (Opioids are drugs with effects similar to opium, such as certain pain medications.) In determining the drug for which to revoke approval, the FDA must prioritize revoking approval for drugs that are not abuse deterrent and consider the public health impact of drugs on the market.","pending_committee_id":2328,"committee":{"committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"},"referrals":[{"date":"2019-02-07","committee_id":2328,"chamber":"S","chamber_id":115,"name":"Health, Education, Labor, And Pensions"}],"history":[{"date":"2019-02-07","action":"Read twice and referred to the Committee on Health, Education, Labor, and Pensions.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":9625,"person_hash":"7pac6cxl","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Joe Manchin","first_name":"Joe","middle_name":"","last_name":"Manchin","suffix":"III","nickname":"","district":"SD-WV","ftm_eid":7573477,"votesmart_id":7547,"opensecrets_id":"N00032838","knowwho_pid":219013,"ballotpedia":"Joe_Manchin_III","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13345,"subject_name":"Drug trafficking and controlled substances"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":1934070,"date":"2019-02-26","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB419\/id\/1934070","state_link":"https:\/\/www.congress.gov\/116\/bills\/s419\/BILLS-116s419is.pdf","text_size":275991,"text_hash":"143381c57ea1b060e3603bdac366c0d9"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}